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Abstract. This study addresses the role of intracellular 
calcium (Ca  2÷) in the expression of iNOS, an IL-1 in- 
ducible gene in human articular chondrocytes. 
The calcium ionophore A23187 and ionomycindid 
not induce NO release or iNOS expression but inhib- 
ited dose dependently IL-l-induced NO release with 
IC50 of 200 nM and 100 nM, respectively. Increased in- 
tracellular Ca  2÷ induced by thapsigargin or cyclopiaz- 
onic acid, inhibitors of the endoplasmic reticulum Ca  2÷ 
ATPase, had similar inhibitory effects with IC50 of 1 
nM and 3 ixM, respectively.  LPS and TNFot induced 
NO production were also suppressed by these  Ca  2÷ 
elevating drugs. 
Levels of IL-l-induced iNOS protein were reduced 
by A23187, thapsigargin, and cyclopiazonic acid. These 
drugs as well as Bay K 8644 and KC1 inhibited IL-1- 
induced iNOS mRNA expression. To analyze the role 
of Ca  2+ in the expression of other IL-1 responsive genes 
in chondrocytes, these Ca  2+ modulating drugs were 
tested for effects on COXII. In contrast to the inhibi- 
tory effects on iNOS mRNA, these drugs induced 
COXII mRNA expression and in combination with 
IL-1, enhanced COXII mRNA levels. Ca  2+ mediated 
increases in COXII mRNA expression were associ- 
ated with an increase in COXII protein. 
The kinetics of Ca  2÷ effects on IL-l-induced iNOS 
mRNA levels suggested a posttranscriptional mecha- 
nism. Analysis of iNOS mRNA half life showed that it 
was 6-7 h in IL-l-stimulated cells and decreased by 
A23187 to 2-3 h. 
In conclusion, these results show that Ca  2÷ inhibits 
IL-l-induced NO release, iNOS protein, and mRNA 
expression in human articular chondrocytes by reduc- 
ing iNOS mRNA stability. Under identical conditions 
increased Ca  2÷ enhances IL-l-induced COXII gene 
and protein expression. 
N 
'ITRIC oxide (NO)  1 is involved as a signaling and ef- 
fector molecule in diverse biological systems (24, 
33).  It is an important  regulator in homeostatic 
cell  functions;  increased  levels  of NO  production  may 
cause cell damage and contribute to the pathogenesis ar- 
thritis,  diabetes and other conditions (39, 41). NO is enzy- 
maticaUy formed from L-arginine by NO synthases (NOS) 
which  have  binding  sites  for  NADPH,  tetrahydrobiop- 
terin,  and  molecular  oxygen.  Constitutive NOS  are pri- 
marily regulated by calcium/calmodulin  (27).  Phosphory- 
lation  of  cNOS  by  protein  kinase  C  (PKC),  cAMP 
dependent protein kinase (PKA) and calcium/calmodulin 
dependent  protein  kinase  (CaM-K)  has  been shown  to 
modulate enzymatic activity (2, 4, 26, 32). In contrast, in- 
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1. Abbreviations  used  in this paper.  COXII, cyclooxygenase  II; CPA, cy- 
clopiazonic acid; GAPDH, glyceraldehyde 3 phosphate dehydrogenase; 
NO, nitric oxide; NOS, NO synthase; iNOS, inducible NOS; PKA, cAMP 
dependent protein kinase; PKC, protein kinase C; RPA, RNAse protec- 
tion assay; TG, Thapsigargin. 
ducible NOS (iNOS) activity appears slowly after expo- 
sure of cells  to cytokines and bacterial products, is sus- 
tained,  depends on RNA and protein synthesis and  the 
enzyme functions independently of calcium and calmodu- 
lin (27). 
cDNAs encoding constitutive enzymes (lb, 3, 20, 23, 35) 
and inducible NOS from macrophages  (44),  hepatocytes 
(12), and chondrocytes (8, 25) have been cloned. In addi- 
tion to these latter three cell types, iNOS expression has 
been  observed in  vascular  smooth  muscle  cells,  kerati- 
nocytes, and  renal mesangial  cells  (6,  16, 29).  Inducible 
NO synthesis has been characterized with respect to the 
identification of extracellular stimuli and a series of proin- 
flammatory cytokines, including IL-1, TNF, interferon-~/ 
(IFN~/), and bacterial lipopolysaccharide (LPS) can induce 
NO synthesis.  Intracellular signals that regulate iNOS ex- 
pression have been characterized in a small number of cell 
types.  Increases  in  intraceUular  cAMP  levels  enhanced 
IFN induced NOS expression in vascular smooth muscle 
cells (21) but partially reduced LPS and IFN-induced NO 
production in murine macrophages (5). PKC appears to be 
involved with iNOS expression in macrophages and hepa- 
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LPS or IL-l-induced NO release in murine macrophages 
and pancreatic islet cells (9, 10). 
Articular chondrocytes activated by single stimuli such 
as IL-1 or LPS produce high levels of NO (28, 30, 38). In a 
previous study we reported that activation of protein ty- 
rosine kinases is required for iNOS mRNA expression in 
these cells (14). Activation of protein kinase A  and pro- 
tein kinase C  did not result in iNOS expression and was 
not required for the effects of IL-1 or LPS. As Ca  2÷ is an 
important signal in the regulation of constitutive NOS and 
there  are  Ca  2÷  sensitive  genes  in  chondrocytes, we  ad- 
dressed in this study the role of Ca  2+ in the regulation of 
IL-l-induced iNOS expression in chondrocytes. We show 
that Ca  2÷ differentially regulates gene expression in chon- 
drocytes. Under identical activation conditions, increased 
intracellular levels of Ca  :÷ inhibit iNOS expression but in- 
creased the expression of other IL-1 inducible genes such 
as cyclooxygenase II. The Ca  2÷  effects on iNOS  are re- 
lated to a reduction in steady state mRNA levels by lower- 
ing iNOS mRNA stability. 
Materials and Methods 
Chondrocyte Isolation and Culture 
Cartilage was obtained at autopsy from donors without known history of 
joint disease. For all experiments reported here, cartilage from the femo- 
ral condyles and tibial plateaus of the knee joints was used. Chondrocytes 
were isolated by collagenase digestion of cartilage and cultured as previ- 
ously described (22).  All experiments were performed with primary or 
passage 1 cells. For studies on the production of NO or iNOS mRNA ex- 
pression, chondrocytes were plated in 96- or 24-well plates at 40,000  or 
250,000  ceils per well, respectively, and cultured in serum-free DMEM 
supplemented with L-glutamine and antibiotics. 
Quantification of Nitrites 
The  concentration of nitrites, the  stable end products  of cellular NO 
breakdown, in conditioned media from chondrocytes was determined by 
the Griess reaction using NaNO2 as standard. All results are expressed as 
nmoles nitrites per 100,000 cells. 
Western Blotting 
Chondrocytes were plated in 6-well plates and stimulated for 24 h. Cells 
were washed once with cold PBS. Cell pellets were lysed by boiling for 5 
min in  20 p,l lysis buffer (1% SDS, 10 mM Tris, pH 7.4), and microfuged 
for 5 min. The supernatants were separated on 10% SDS-PAGE and the 
proteins transferred to nitrocellulose membrane (Schleicber &  Schuell, 
Inc., NC TM, Keene, NH). The blots were blocked with 5% BSA overnight 
at  4°C,  and incubated with primary antibody to iNOS  or COX-2. For 
iNOS  a  murine monoclonal antibody raised against a  COOH-terminal 
fragment of iNOS (Transduction Laboratories, Lexington, KY) was used. 
COX-2  was  detected  with  a  rabbit  anti-prostaglandin  H  synthase  II 
(COX-2) polyclonal antibody (Cayman Chemical Co., Ann Arbor, MI) at 
1:1,000 dilution for 1 h at room temperature. After five washes with TBS/ 
Tween (125 mM NaCI, 25 mM Tris, pH 8.0, 0.1% Tween 20), the blots 
were incubated with horseradish peroxidase--conjugated goat anti-rabbit 
or anti-mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, 
PA) in TBS with 1% BSA for 1 h  at room temperature. After 30 min 
washing with TBS/Tween, the blots were incubated with ECL substrate 
solution (Amersham Corp., Arlington Heights, IL) for 1 rain according to 
the manufacturer's instructions.  After 30-60 min, the blots were exposed 
to X-ray film for 10-30 s. To document the amounts of protein loaded in 
the different lanes, the blots were probed with antibody to MAP kinase 
(Zymed Laboratories, South San Francisco, CA). Although IL-1 induces 
phosphorylation of MAP kinase in chondrocytes, it does not alter the lev- 
els of MAP kinase proteins (Geng, Y., and M. Lotz, unpublished). 
Ribonuclease Protection Assay (RPA) 
A 236-bp PCR fragment from 2125 to 2360 nt of the iNOS eDNA (12) was 
inserted into the transcription vector PT7 (Novagen, Madison, WI), and 
subcloned into pGEM3z.  The plasmid was linearized with BamHI. A 292- 
bp' fragment from nucleotides 1522 to 1813 of the COX-2 eDNA (kindly 
provided by Dr. Ben Bowen, Ciba Geigy Corp., Summit, NJ) was sub- 
cloned into the transcription vector pGEM4z (Promega, Madison, WI) at 
the SacI and PstI sites. The plasmid was linearized with NcoI to produce a 
194-nt  antisense  COX-2  probe.  The  cloned  and  linearized  GAPDH 
eDNA was purchased from Continental Scientific Inc. (San Diego, CA). 
The radiolabeled antisense riboprobes were prepared by in vitro tran- 
scription with SP6 RNA polymerase with the incorporation of [ct-32p]UTP 
(Amersham Corp.) containing RNasin, D'IT, NTP, and 200 ng of the lin- 
earized template. The samples were incubated at 37°C for 1 h. The DNA 
templates were digested with RNase-free DNase I (Stratagene, La Jolla, 
CA). 32p[UTP]-labeled probe was extracted with phenol-chloroform, pre- 
cipitated with isopropanol, and dissolved in 20 p,l hybridization buffer. 
Total RNA was isolated with RNA STAT from 10  ~ cells and 2-5 ~g of 
RNA was dissolved in 10 ttl of DEPC treated dH20. The RNA samples 
were mixed with 2 × hybridization buffer (Continental Scientific) contain- 
ing 1  ×  105 cpm [ct-32p]UTP-labeled  antisense riboprobe.  The sample 
RNA and riboprobe were denatured at 90°C for 5 min and then hybrid- 
ized at 55°C for 14 h. Unhybridized RNA was digested with ribonuclease 
(RNase) T1 50 U/ml (GIBCO BRL, Gaithersburg, MD) and RNase A 10 
~g/ml (Sigma Chemical Co., St. Louis, MO) at 37°C for i h. The digestion 
reaction was terminated by adding stopping buffer (Continental Scientific 
Inc.) and the protected RNA fragments were precipitated.  The samples 
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Figure 1.  Increased intracel- 
lular  Ca  2+  inhibits  IL-1- 
induced NO production. Hu- 
man  articular  chondrocytes 
were  stimulated  with  IL-113 
(1  ng/ml)  and  treated simul- 
taneously  with  the  calcium 
ionophore A23187 (A) or the 
endoplasmic  reticulum  Ca  2+ 
ATPase inhibitors thapsigar- 
gin (TG, panel B) or cyclopi- 
azonic acid (CPA, panel  C). 
Nitrite  levels  were  deter- 
mined  in  48  h  conditioned 
media by the Griess reaction. 
Results  represent  mean  --- 
SEM  of  three  separate  ex- 
periments  performed  in  du- 
plicate. 
The Journal of Cell Biology, Volume 129, 1995  1652 were dissolved in RNA loading buffer, denatured at 90°C and electro- 
phoresed on 6% polyacrylamide  gels. After transfer to chromatography 
paper, the gels were exposed to Kodak film overnight. 
Analysis of mRNA Stability 
Chondrocytes were stimulated with IL-1 for 12 h and then treated with 
A23187 for 2 h. The cells were then treated with actinomycin  D (5 i±g/ml) 
and harvested from replicate flasks 0--12  h later for RNA isolation. Levels 
of iNOS and GAPDH mRNA were analyzed  by RPA. 
Reagents 
Recombinant human IL-113  was purchased from R&D Systems (Minneap- 
olis, MN). Thapsigargin,  cyclopiazonic  acid, and Bay K 8644 were pur- 
chased from Sigma Chem. Co., calcium  ionophore A23187 and ionomycin 
from  Calbiochem (La  Jolla, CA).  Thapsigargin, cyclopiazonic acid, 
A23187, and ionomycin  were dissolved  in dimethyl  sulphoxide (DMSO) at 
5 mg/ml. 
Results 
Increased Intracellular  Ca  2+ Is Associated  with 
Inhibition of lL-l-induced NO Release 
The  calcium  ionophore  A23187  when  added  in  the  ab- 
sence of other stimuli to primary cultures of human articu- 
lar  chondrocytes  did  not  induce  NO  release  or  iNOS 
mRNA expression (14). In combination with IL-1, A23187 
inhibited  dose dependently  the release  of NO  (Fig.  1 A) 
with an IC50 of 200 nM. Ionomycin had similar inhibitory 
effects  with  IC50 of 100  nM  (not  shown).  These  results 
suggested that increased intracellular  Ca  2÷ inhibits induc- 
ible NO synthesis.  To confirm this,  other mechanisms to 
increase intracellular Ca  2+ were tested. Thapsigargin (TG) 
and cyclopiazonic acid (CPA) increase  intraceUular  Ca  2+ 
by specifically inhibiting  the endoplasmic reticulum  Ca  2+ 
ATPase (34, 42). These reagents also failed to induce NO 
release (not shown) but inhibited the IL-1 effect with IC50 
of 1 nM and 3 }xM, respectively (Fig. 1, Band C). LPS and 
TNFa are potent NO inducers in chondrocytes and their 
effects were also inhibited by the Ca  2÷ elevating drugs (not 
shown). 
Inhibition  of lL-l-induced iNOS Protein Levels by 
Calcium Ionophore and ATPase Inhibitors 
The  CaZ+-mediated  inhibition  of NO  synthesis  could  be 
mediated by different mechanisms such as inhibition of co- 
factor  synthesis,  posttranslational  modifications  of  the 
iNOS  enzyme  or  effects  on  iNOS  protein  synthesis  or 
mRNA accumulation. The next set of experiments exam- 
ined  iNOS protein  levels  by Western  blotting.  Unstimu- 
lated  chondrocytes  did  not  contain  detectable  levels  of 
iNOS protein.  In response to IL-1, there was a  strong in- 
crease in the intensity of the iNOS band at 145 kD. When 
IL-1 was combined with A23187 or TG, only a weak iNOS 
protein signal was detectable (Fig. 2). These findings show 
that in the presence  of drugs which increase intracellular 
Ca  2+, IL-l-induced iNOS protein levels are reduced  and 
this  may  account for the  observed  inhibition  of NO  re- 
lease. 
Increased Intracellular  Ca  2+ Is Associated  with 
Selective Inhibition  of iNOS and Enhanced COXII 
Protein Expression 
Since prolonged increases  in intracellular  Ca  2÷ levels can 
induce apoptosis by the activation of endonucleases, chon- 
drocyte viability was assessed by trypan blue dye exclusion 
and cells were examined for apoptotic changes. This showed 
Figure 2.  Effect of increased intracellular Ca  2÷ on iNOS protein 
synthesis.  Chondrocytes were  stimulated  with  IL-l[3 (1  ng/ml) 
alone or in the presence of A23187 (500 nM) or TG (100 nM). 
Cell lysates were prepared after 24 h  and analyzed by Western 
blotting.  Blotting of the identical filter for MAP kinase  shows 
that the different lanes contain similar amounts of protein. 
Figure 3.  Ca  2+ differentially  regulates  IL-l-induced iNOS  and 
COXII protein synthesis.  Chondrocytes were stimulated with IL- 
l[3 (1 ng/ml) alone or in the presence of the indicated concentra- 
tions of CPA.  Cell lysates were prepared after 24 h and analyzed 
by Western blotting with antibody to COXII. The same blot was 
subsequently probed with antibody to iNOS. The weak bands at 
71 kD in the iNOS figure are traces of the COXII signal. The dif- 
ferent lanes contained identical  amounts of protein  as demon- 
strated by Western blotting for MAP kinase (not shown). 
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nation with IL-1 were causing cell death at the doses used 
in these experiments. To address selectivity of the Ca  2÷ ef- 
fects, the synthesis  of cyclooxygenase 2  (COXII), a  Ca  2÷ 
inducible  protein,  was examined.  COXII and  iNOS pro- 
teins  were  analyzed  in  the  identical  cell  lysates.  Neither 
COXII nor iNOS were  detectable  in  unstimulated  chon- 
drocytes.  IL-1  induced  the  synthesis  of  both  proteins. 
However, when the Ca  2÷ ATPase inhibitor CPA was com- 
bined with  IL-1, there  was a  dose-dependent  increase  in 
COXII protein  synthesis  and  a  simultaneous  decrease  in 
iNOS  protein  synthesis  (Fig.  3).  These  results  suggested 
specificity and selectivity of Ca  2÷ effects, since under iden- 
tical  conditions  the  synthesis  of two  IL-1  inducible  pro- 
teins was differentially regulated. 
Ca  2+ Effects on IL-l-induced iNOS and COXII 
mRNA Accumulation 
iNOS  protein  synthesis  can  be  modulated  under  condi- 
tions where steady state mRNA levels are unchanged (43). 
A  RNAse  protection  assay  was  used  to  quantify  iNOS 
mRNA  and  determine  effects  of increased  intracellular 
Ca  2+ on steady state mRNA levels of IL-l-induced genes. 
To determine  selectivity of the  Ca  2÷ modulating drug ef- 
fects, iNOS mRNA was quantified in the same hybridiza- 
tion solutions with COXII and GAPDH. iNOS and COXII 
mRNA were not expressed in unstimulated cells. After 12 h 
both mRNAs were readily detectable (Fig. 4). A23187 and 
the  two  Ca  2+ ATPase  inhibitors  almost  completely  in- 
hibited  IL-l-induced iNOS mRNA accumulation.  Bay K 
8644, a  Ca  2÷ channel agonist, was less potent but still re- 
suited in a 40% reduction and KC1 caused 90% inhibition. 
In contrast to this inhibition of iNOS, all of the Ca  2÷ regu- 
lators increased COXII mRNA levels. 
These findings indicate Ca  2÷ suppression of NO release 
and iNOS protein levels are associated with inhibition  of 
iNOS  mRNA  accumulation.  Under  identical  conditions 
increased levels of intracellular Ca  >  differentially regulate 
IL-l-induced  COXII  gene  expression  in  chondrocytes 
while  not affecting the  constitutively expressed  GAPDH 
mRNA. 
Increased lntracellular Ca  2+ Reduces iNOS 
mRNA Stability 
To further characterize  the Ca  >  effects on IL-l-induced 
iNOS gene expression, incubation times of IL-1 and A23187 
as  well  as  the  sequence  of their  addition  were  modified 
and iNOS mRNA levels were examined at different time 
points. When RNA was isolated 6 h after IL-1 stimulation, 
addition  of A23187 2 h  before or 3  h  subsequent  to IL-1 
did not reduce iNOS mRNA  levels.  Only when the cells 
were preincubated with A23187 for 4 h, there was a moder- 
ate reduction in IL-l-induced iNOS mRNA levels (Fig. 5 A). 
IL-l-induced iNOS mRNA in chondrocytes shows pro- 
Figure 4.  Ca  2+ effects on IL-l-induced iNOS and COXII mRNA 
expression. Chondrocytes were stimulated with IL-113 (1 ng/ml) 
in the presence of A23187 (1 IxM), CPA (25 ixM), TG (1 ~M), 
Bay K 8644 (25 ~M), and KC1 (50 mM). Cells were harvested af- 
ter 12 h for RNA extraction, iNOS, COXII, and GAPDH RNA 
levels  were determined by RNAse protection assay in the same 
hybridization reactions. The autoradiograph shows the expected 
236 bp and 194-bp protected bands for iNOS and COXII. 
Figure  5.  Kinetics  of  A23187  effects  on  IL-l-induced  iNOS 
mRNA expression.  Chondrocytes were stimulated with IL-113 
(1  ng/ml)  and  A23187  (1  ~M)  was  added  1-4  h  before  IL-1 
(+1,+2,+4),  at the same time as IL-1 (0) or 1- 12 h later than IL-1 
(-1 to -12). Cells were harvested 6 h after IL-1 addition (A) or 
24 h after IL-1 (B). iNOS and GAPDH mRNA levels were ana- 
lyzed by RNAse protection assay. 
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Figure  6.  Increased intracellular  Ca  2÷ and  IL-1  induced  iNOS 
mRNA stability. Chondrocytes were stimulated with IL-113 (1 ng/ 
ml) for 12 h, followed by the addition  of A23187 (500 nM). After 
2 h actinomycin  D  (5 ~g/ml) was added and cells from replicate 
flasks were harvested 0-12 h later. RNA expression was analyzed 
by RPA. The autoradiographs were subjected  to densitometry 
and the iNOS values were normalized on the basis of the values 
for  GAPDH.  A  value  of 5  was  arbitrarily  assigned  to  iNOS 
mRNA levels at time 0. A is representative of three separate ex- 
periments.  B shows mean values from the three experiments. 
longed duration of expression and in the same culture, af- 
ter addition of IL-1 only at initiation, RNA levels remain 
elevated for up to 3 d  (14). It was thus possible that Ca  2÷ 
affects  IL-l-induced  iNOS  at  later  time  points.  When 
RNA expression was examined 24 h after IL-1 stimulation, 
more potent effects of A23187 were observed. There was 
>90%  inhibition  of iNOS  mRNA levels even when  the 
ionophore was added 8 h later than IL-1 (Fig. 5 B). Collec- 
tively, these  results showed that  the  Ca  2÷ suppression  of 
iNOS  mRNA  accumulation  is  delayed  in  onset  and  in- 
creases strongly as a  function  of time.  Since A23187  did 
not inhibit the early induction but the later accumulation 
of iNOS mRNA, this suggested that Ca  2+ may not affect 
iNOS  transcription  but  probably alters  mRNA  stability. 
To examine this, cells were stimulated with IL-1 in the ab- 
sence or presence of A23187 and mRNA stability was de- 
termined by adding actinomycin D  12 h after IL-1 and col- 
lecting cells  at  several subsequent  time points for RNA 
extraction.  Based  on  these  experiments  the  half  life  of 
iNOS mRNA in IL-l-stimulated chondrocytes was 6-7 h. 
The calcium ionophore reduced iNOS mRNA half life to 
2-3 h  (Fig. 6, Aand B). These findings show that the Ca  2+ 
suppression of NO release, iNOS protein, and steady state 
mRNA levels are related to a selective reduction in iNOS 
mRNA stability. 
Discussion 
This study addresses the role of intracellular  Ca  z+ in the 
regulation  of inducible  NO  synthesis  in  human  articular 
chondrocytes.  Intracellular  levels  of  Ca  2÷  increased  by 
Ca  2+ ionophore or inhibitors of Ca  2+ ATPase inhibit NO 
release,  iNOS  protein  synthesis,  and  iNOS  steady  state 
mRNA levels. This is associated with a CaE÷-mediated re- 
duction of iNOS mRNA stability. We also show that under 
identical conditions where increased intracellular Ca  2÷ has 
these  inhibitory  effects on  iNOS,  it  enhances  the  IL-1- 
induced expression of COXII. NOS isoforms are distinct 
with respect to their sensitivity to Ca  2÷ levels. The activi- 
ties  of the  constitutive  enzymes purified from brain  and 
endothelial  cells  are  regulated  by  the  intracellular  free 
Ca  2+ concentration and the CaE+-binding protein calmod- 
ulin.  Macrophage iNOS is Ca  2+  independent.  In contrast 
to  most  CaM-dependent  enzymes,  macrophage  iNOS 
binds  CaM  tightly  without  a  requirement  for  elevated 
Ca  2+ (27). Endotoxin-induced NOS from liver differs from 
the  inducible  enzyme found  in  macrophages  and  is  un- 
usual in that it is stimulated by calmodulin with little de- 
pendence on the Ca  2+ concentration (12). iNOS activity in 
extracts from  IL-l-stimulated  human  articular  chondro- 
cytes is not dependent on calcium (28). 
Transcriptional regulation of iNOS shows cell type and 
stimulus-dependent  differences.  In  chondrocytes  iNOS 
mRNA  expression  is  induced  by proinflammatory cyto- 
kines such as IL-1, TNF, and by bacterial lipopolysaccha- 
ride  and remains detectable  at high levels for prolonged 
time periods (28, 30, 38). We showed that the second mes- 
senger agonists PMA, cAMP, and A23187 did not induce 
NO release or iNOS mRNA expression. By using specific 
kinase inhibitors we found that PKA and PKC were not 
required  for  the  IL-1  induction  of  iNOS  mRNA  (14). 
However, the induction  of iNOS mRNA and NO release 
by IL-1 and LPS were dependent on activation of tyrosine 
kinases which  are also important for iNOS expression in 
macrophages and renal mesangial cells (9, 10). 
With  this background  the  present  study addressed  the 
role of Ca  2+ in the regulation of NO production in human 
articular chondrocytes. We found that thapsigargin and cy- 
clopiazonic acid which increase intracellular Ca  2÷ by inhib- 
iting Ca  2+ ATPase did not induce NO synthesis or iNOS 
mRNA expression and thus had similar effects as A23187 
(14). To address a possible involvement of Ca  2÷ in the IL-1 
induction of NO synthesis, Ca  2÷ chelators were tested and 
found  not  to  affect  IL-l-induced  NO  release  or  iNOS 
mRNA levels (Geng, Y., and M. Lotz, unpublished).  Col- 
lectively, these results suggest that in chondrocytes, Ca  2+ 
does not induce NO synthesis and is not required for the 
IL-1 effects. 
We then  examined whether  Ca  2+  has negative regula- 
tory effects on NO synthesis. These studies showed that all 
drugs which increase Ca  2÷ inhibited IL-l-induced NO syn- 
thesis and reduced iNOS protein and steady state mRNA 
levels. Although an effect of Ca  2÷ on iNOS enzymatic ac- 
tivity cannot be excluded, it appears that it acts primarily 
by altering iNOS mRNA levels. Studies on the kinetics of 
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significant reduction of iNOS mRNA half life by A23187 
was demonstrated.  The effects  of Ca  2÷ on iNOS  mRNA 
were slow in onset, possibly suggesting a protein synthesis- 
dependent mechanism. These results  support the hypoth- 
esis that Ca  2÷ regulates a protein which controls stability 
of iNOS mRNA. The 3' untranslated region of murine and 
human iNOS contains a conserved region which is almost 
identical to the UUAUUUAU  octanucleotide sequence in 
the TNF mRNA (11). This region confers mRNA instabil- 
ity  and  represents  a  binding  motif for labile,  cyclohexa- 
mide-sensitive  proteins  (7,  31,  37).  Consistent  with  this, 
the half life of iNOS mRNA is prolonged in the presence 
of CHX and in some cell types such as chondrocytes and 
smooth muscle cells  CHX  alone in the  absence of other 
iNOS  inducers causes the accumulation of iNOS  mRNA 
(11).  Whether  the  cyclohexamide  and  Ca  2÷ act  via  the 
same protein will require analysis of modified 3'  ends of 
the iNOS mRNA.  However, the present findings provide 
further support for the importance of mRNA stability in 
the regulation of iNOS. These results also represent to our 
knowledge  the  first  example  where  Ca  2÷,  which  is  well 
known  to  stabilize  mRNAs,  causes  more  rapid  mRNA 
degradation. 
The inhibitory effects of Ca  2÷ modulating drugs on IL- 
l-induced gene expression in chondrocytes were not glo- 
bal but selective. In contrast to the inhibition of iNOS, un- 
der identical conditions (identical cells, culture conditions, 
incubation times) Ca  2÷ induced the expression of COXII 
and significantly  enhanced the IL-1  effect.  These  results 
are consistent with the regulation of COXII as an immedi- 
ate early gene which is known to be induced by elevated 
levels of intracellular Ca  2÷ (13). It is furthermore of inter- 
est  that  COXII  ca.n  be  induced  by  PKC  activation  via 
PMA and that this pathway does not lead to iNOS expres- 
sion. These findings suggest that within the set of IL-1 in- 
ducible genes in a given cell type, the same second messen- 
ger can be a stimulus for one and an inhibitor for another. 
Thus, although Ca  2÷ may not be part of IL-l-initiated sec- 
ond messengers, the present results demonstrate that the 
Ca  2+ levels  can profoundly  alter the  cellular  response  to 
this cytokine. Information on Ca  2÷ in IL-l-activated chon- 
drocytes is limited but available evidence suggests that al- 
though  IL-1  strongly  altered  the  pattern  of  phosphory- 
lated proteins it did not induce protein kinases activated 
by Ca2+/calmodulin (19). 
The present findings of increased levels of intracellular 
Ca  2+  being  associated  with  inhibition  of iNOS  are  also 
consistent with the role of Ca  2÷ and NO in the regulation 
of chondrocyte mitogenesis. Growth factors such as plate- 
let-derived  growth factor increase inositol phosphate hy- 
drolysis  and  cytoplasmic  Ca  2÷  in  chondrocytes  (40).  In 
contrast, IL-1  inhibits  chondrocyte proliferation induced 
by serum or growth factors (15).  These inhibitory effects 
of IL-1  are mediated by NO  as NO  derived from exoge- 
nous sources inhibits cell proliferation and the antiprolif- 
erative effects of IL-1  are neutralized by the NOS inhibi- 
tor NMA (Blanco, F., and Lotz, M. unpublished). Thus, in 
the regulation of cell proliferation increased levels of Ca  2÷ 
are associated with the suppression of NO synthesis. 
In conclusion, the present results suggest that intracellu- 
lar levels of Ca  2+ differentially modulate chondrocyte gene 
expression  as  demonstrated  for  iNOS  and  COXII, two 
IL-1 inducible genes. The effects on iNOS are related to a 
decrease  in mRNA stability and  are consistent with the 
role  of NO  and  Ca  2÷  in  the  regulation  of chondrocyte 
function. 
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